Healthcare Portfolio Is Doing Well But Biotech Stocks Are Mired in Macro…Update-4…rally in spec biotechs!

Update-4...1/6/23...Broad rally sparked by latest economic data anticipating weaker economy and slowing wage growth . Bond yields are down.  A '"soft landing '"scenario? We are at the JPMorgan Healthcare Conference next week. Closing trades: XLV at $135.67,   IBB at $133.14,  XBI at $83.16...

Pin It on Pinterest